OptimizeRx Corp. OPRX 深 滬
等待開盤 09-10 09:30:00 美东时间
17.79
-0.500
-2.73%
華盛通- 最 高18.57
- 今 開18.50
- 成交量 24.38万股
- 最 低 17.77
- 昨 收 18.29
- 總市值 3.29亿
- 52周最高 19.25
- 市盈率 靜 --
- 換手率 1.32%
- 52周最低 3.78
- 委 比 93.19%
- 總股本 1849.51万
- 歷史最高 99.178
- 量 比 0.69
- 振 幅 4.37%
- 歷史最低 3.78
- 每 手 1
- 風險率 3.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多OptimizeRx Partners With Lamar Advertising To Revolutionize OOH Advertising For Pharmaceutical And Healthcare Brands
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare MarketingWALTHAM, Mass., Sept. 09, 2025
今天 04:14
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
OptimizeRx and Lamar Advertising Company have formed a strategic partnership to enhance out-of-home (OOH) advertising for healthcare brands. By integrating OptimizeRx's patented Micro-Neighborhood Targeting (MNT) data with Lamar's全国户外广告网络，双方为制药企业提供精准的临床相关户外广告解决方案，同时保持成本效益和可衡量的结果。
09-09 20:05
OptimizeRx Appoints Brendan Merrell As COO
OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced
08-19 19:39
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading healthcare technology company, announced organizational updates and leadership advancements to accelerate its Rule of 40 strategy, balancing growth and profitability. CEO Steve Silvestro highlighted the Company’s confidence in its talent and commitment to strategic clarity. Key leadership changes include Ed Stelmakh as Chief Financial & Strategic Officer,...
08-19 11:30
Stifel Maintains Buy on OptimizeRx, Raises Price Target to $18
Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and raises the price target from $16 to $18.
08-08 22:30
OptimizeRx shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.
OptimizeRx shares are trading higher after the company reported better-than-exp...
08-08 04:58
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
OptimizeRx Corp. will host a conference call on August 7, 2025, at 4:30 p.m. Eastern Time, to discuss its second quarter 2025 financial results. The call will feature OptimizeRx management and include a Q&A session. Details to join the call or webcast are provided, along with instructions to dial in or log on five minutes prior to the start. A replay will be available for 12 months on the company's website. OptimizeRx is a healthcare technology c...
07-17 11:30
A Look Ahead: Simulations Plus's Earnings Forecast
Simulations Plus (NASDAQ:SLP) is gearing up to announce its quarterly earnings ...
07-11 22:01
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
OptimizeRx Corp. announced on June 24, 2025, that Steve Silvestro, currently serving as CEO, has been appointed to its Board of Directors, effective June 20, 2025. Silvestro joined the Company in 2019 and became CEO in March 2025 after serving as interim CEO since January 2025. His appointment is expected to enhance leadership and support the Company’s strategic initiatives to deliver value for customers and shareholders. Silvestro expressed his ...
06-24 11:30
